Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice.
Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice.
复制标题
合成具有小鼠体内抗骨髓瘤作用的骨靶向硼替佐米。
DOI:
10.3390/pharmaceutics10030154
复制
发表时间:
2018-09-10
期刊:
影响因子:
5.4
通讯作者:
Xing L
中科院分区:
文献类型:
--
作者:
Wang H;Xiao L;Tao J;Srinivasan V;Boyce BF;Ebetino FH;Oyajobi BO;Boeckman RK Jr;Xing L
Multiple myeloma (MM) is the most common cancer affecting the bone and bone marrow and remains incurable for most patients; novel therapies are therefore needed. Bortezomib (Btz) is an FDA-approved drug for the treatment of patients with MM. However, its severe side effects require a dose reduction or the potential discontinuation of treatment. To overcome this limitation, we conjugated Btz to a bisphosphonate (BP) residue lacking anti-osteoclastic activity using a novel chemical linker and generated a new bone-targeted Btz-based (BP-Btz) proteasome inhibitor. We demonstrated that BP-Btz, but not Btz, bound to bone slices and inhibited the growth of MM cells in vitro. In a mouse model of MM, BP-Btz more effectively reduced tumor burden and bone loss with less systemic side effects than Btz. Thus, BP-Btz may represent a novel therapeutic approach to treat patients with MM.
登录
查看更多内容
影响因子:
5.7
作者:
Hideshima T;Richardson PG;Anderson KC
通讯作者:
Anderson KC
影响因子:
10.5
作者:
Zinszner, H;Kuroda, M;Ron, D
通讯作者:
Ron, D
DOI:
10.1073/pnas.220247197
发表时间:
2000-11-07
影响因子:
11.1
作者:
Brewer, JW;Diehl, JA
通讯作者:
Diehl, JA
影响因子:
5.3
作者:
Cavaletti, Guido;Gilardini, Alessandra;De Coster, Roland
通讯作者:
De Coster, Roland
DOI:
10.3324/haematol.2009.012674
发表时间:
2010-02-01
期刊:
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子:
--
作者:
Mohty, Bilal;El-Cheikh, Jean;Mohty, Mohamad
通讯作者:
Mohty, Mohamad